Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials

OBJECTIVES: Under representation of black subjects in trials of hepatitis C virus (HCV) direct-acting antivirals (DAAs) complicates assessment of differential outcomes for black individuals vs non-black individuals. HCV trials submitted to the Food and Drug Administration (2013–2017) to support appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Struble, Kimberly, Chan-Tack, Kirk, Qi, Karen, Valappil, Thamban, Connelly, Sarah, Mishra, Poonam, Price, Dionne, Murray, Jeffrey, Birnkrant, Debra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816118/
https://www.ncbi.nlm.nih.gov/pubmed/31700657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816118/
https://www.ncbi.nlm.nih.gov/pubmed/31700657

Ejemplares similares